|
|
|
Volumn 16, Issue 6, 1986, Pages 453-457
|
|
Neurophysiological variables and fibrinolysis in insulin-dependent diabetes treated with an aldose reductase inhibitor or placebo: A double-blind randomized study
a a a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALDEHYDE REDUCTASE;
ALDOSE REDUCTASE INHIBITOR;
INSULIN;
SORBINIL;
TISSUE PLASMINOGEN ACTIVATOR;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG INTERACTION;
ENDOCRINE SYSTEM;
FIBRINOLYSIS;
HUMAN;
HUMAN EXPERIMENT;
INSULIN DEPENDENT DIABETES MELLITUS;
METHODOLOGY;
NERVOUS SYSTEM;
NEUROPATHY;
ORAL DRUG ADMINISTRATION;
PREVENTION;
PRIORITY JOURNAL;
SUBCUTANEOUS DRUG ADMINISTRATION;
THERAPY;
ALDEHYDE REDUCTASE;
DIABETES MELLITUS, INSULIN-DEPENDENT;
DIABETIC NEUROPATHIES;
FIBRINOLYSIS;
GLYCOPROTEINS;
HUMAN;
IMIDAZOLES;
LONGITUDINAL STUDIES;
PLACEBOS;
PLASMINOGEN INACTIVATORS;
RESEARCH DESIGN;
SUGAR ALCOHOL DEHYDROGENASES;
SUPPORT, NON-U.S. GOV'T;
TISSUE PLASMINOGEN ACTIVATOR;
|
|
EID: 0022881468
PISSN: 03010147
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (8)
|
|
References (0)
|